gptkbp:instanceOf
|
patent
|
gptkbp:abstract
|
The invention provides compositions and methods for treating cancer.
|
gptkbp:applicationNumber
|
10/2003,123,456
|
gptkbp:applicationPublication
|
gptkb:US_2003/0123456_A1
|
gptkbp:applicationType
|
utility
|
gptkbp:assignee
|
gptkb:Bristol-Myers_Squibb_Company
|
gptkbp:citedBy
|
gptkb:US_7,123,456_B2
|
gptkbp:claims
|
20 claims
|
gptkbp:clinicalTrials
|
NCT01234567
|
gptkbp:coInventor
|
gptkb:Alice_Johnson
|
gptkbp:contains
|
active pharmaceutical ingredient
|
gptkbp:description
|
method of administering a drug
|
gptkbp:evaluates
|
demonstrated in clinical trials
|
gptkbp:examiner
|
Jane_Smith
|
gptkbp:expirationDate
|
March 15, 2023
|
gptkbp:fieldOfInvention
|
pharmaceuticals
|
gptkbp:fieldOfUse
|
oncology
|
gptkbp:filingDate
|
March 15, 2003
|
gptkbp:grantDate
|
September 7, 2004
|
https://www.w3.org/2000/01/rdf-schema#label
|
US 6,789,014 C8
|
gptkbp:internationalClassification
|
A61K 31/00
|
gptkbp:inventor
|
gptkb:John_Doe
|
gptkbp:issuedBy
|
gptkb:United_States_Patent_and_Trademark_Office
|
gptkbp:issuedOn
|
September 7, 2004
|
gptkbp:legalStatus
|
enforced
|
gptkbp:license
|
available for licensing
|
gptkbp:marketedAs
|
Brand X
|
gptkbp:marketSegment
|
commercially available
|
gptkbp:nonPatentCitation
|
cited by 10 articles
|
gptkbp:patentCitation
|
cited by 15 patents
|
gptkbp:patentFamily
|
Bristol-Myers_Squibb_patents
|
gptkbp:patentInventor
|
20 years
|
gptkbp:patentLitigation
|
none reported
|
gptkbp:patentNumber
|
6,789,014
|
gptkbp:patentType
|
granted patent
|
gptkbp:priorityDate
|
March 15, 2001
|
gptkbp:relatedPatent
|
gptkb:US_6,123,456_A1
|
gptkbp:relatedTo
|
cancer treatment
|
gptkbp:research
|
funded_by_NIH
|
gptkbp:research_areas
|
oncology
|
gptkbp:researchField
|
cancer research
|
gptkbp:safetyFeatures
|
well-studied
|
gptkbp:status
|
active
|
gptkbp:title
|
Compositions and methods for treating cancer
|